XATRAL 2.5 MG

Country: Իսրայել

language: անգլերեն

source: Ministry of Health

active_ingredient:

ALFUZOSIN HYDROCHLORIDE 2.5 MG

MAH:

SANOFI - AVENTIS ISRAEL LTD

ATC_code:

G04CA01

pharmaceutical_form:

TABLETS

administration_route:

PER OS

manufactured_by:

SANOFI WINTHROP IND., FRANCE

therapeutic_group:

ALFUZOSIN

therapeutic_indication:

Treatment of certain functional symptoms of benign prostatic hypertrophy, notably when surgery has to be delayed for whaterver reason and during episodes of severe symptoms of adenoma, especially in elderly patients.

authorization_date:

2008-12-01